Early stage drug Development
Fully integrated services for speed, flexibility and efficiency.
The pharmaceutical development supply chain is complicated. Most active pharmaceutical ingredients (API) suppliers offer either process development or commercial manufacturing, not both. Few offer both drug substance and drug product capabilities. Only Patheon, a part of Thermo Fisher Scientific, offers a seamless, end-to-end development solution. An elegantly simple supply chain that from the earliest phases aligns people, technologies and operations for a coordinated push toward first-in-human studies and proof of concept success.
For both biologics (large molecules) and small molecules (APIs), our drug development experts gives you access to a full breadth of advanced scientific and preformulation services to meet all your early development needs.
- Rapidly characterize your drug substance
- Quickly evaluate formulation options
- Overcome formulation challenges such as low solubility
- Gain a clear view of your path through in-vitro, preclinical and clinical studies
- Develop and manufacture fit-for-purpose early-phase clinical materials
- Design, validate and implement analytical and process methodologies
- Generate the data required for IND filings
At every step, our early development experts will guide you with advice founded in the experience of thousands of projects. One partner, one team, one seamless process. Patheon, a part of Thermo Fisher Scientific, is the most rapid and cost-effective way to achieve early clinical success. You’ll be well positioned with maximum investment value and a firm scientific foundation for the work ahead.